<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> with recurrent oral and/or <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulcerations</z:e>, <z:mp ids='MP_0001212'>skin lesions</z:mp>, and ocular involvement </plain></SENT>
<SENT sid="1" pm="."><plain>Eye involvement is a common manifestation that affects the patients' quality of life more than any other </plain></SENT>
<SENT sid="2" pm="."><plain>Left untreated, it leads to <z:hpo ids='HP_0000618'>blindness</z:hpo> and often to loss of the eye through secondary complications such as <z:e sem="disease" ids="C0041327" disease_type="Disease or Syndrome" abbrv="">phthisis</z:e> or painful <z:hpo ids='HP_0000501'>glaucoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Case report of a 24-year-old patient of Turkish descent living in Germany since his birth was admitted to our Department of Ophthalmology in 1999 because of <z:hpo ids='HP_0000572'>visual loss</z:hpo> in his right eye </plain></SENT>
<SENT sid="4" pm="."><plain>He could only perceive light in that eye and evidenced total <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In the left eye he had 20/20 vision but showed signs of <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:mp ids='MP_0001863'>vascular inflammation</z:mp> and secondary <z:hpo ids='HP_0000501'>glaucoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Treatment with interferon alpha (9x10(6) I.U./3x week s.c.) and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (100 mg/d p.o.) led to complete regression of the <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> within 2 weeks prior to operation </plain></SENT>
<SENT sid="7" pm="."><plain>Vitrectomy was then successfully performed in the right eye under the therapy of interferon alpha (9x10(6) I.U./3x week s.c.) and 10 mg <z:chebi fb="2" ids="8378">prednisolone</z:chebi> p.o </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:chebi fb="2" ids="8378">prednisolone</z:chebi> therapy was stopped 1 week following operation </plain></SENT>
<SENT sid="9" pm="."><plain>The failure of conservative <z:hpo ids='HP_0000501'>glaucoma</z:hpo> treatment necessitated trabeculectomy in the left eye </plain></SENT>
<SENT sid="10" pm="."><plain>The patient has had no further recurrence for 4 years under monotherapy with interferon alpha (3x10(6) I.U./3x week s.c.) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Interferon alpha is a potent therapy for Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease with ocular involvement </plain></SENT>
<SENT sid="12" pm="."><plain>It also provides a basis for safe and reliable surgical interventions </plain></SENT>
<SENT sid="13" pm="."><plain>There was no intra- or perioperative recurrence of <z:mp ids='MP_0001845'>inflammation</z:mp>, which is a common finding in these procedures </plain></SENT>
</text></document>